About HEMA
Health technology assessment (HTA) is an established practice, conducted by many agencies and research organizations worldwide. Some variation in methods across organizations is necessary — it reflects local preferences and priorities. There is also significant value in evaluating new methods as an international community before they are considered for local implementation.
HEMA aims to:
- Examine selected topics — Through the working group and topic specific experts, HEMA will explore topics that include potential benefits, disadvantages, and uncertainties associated with methods, and couple this review with empirical investigation and worked examples where appropriate.
- Provide guidance and recommendations to the HTA community — this guidance may relate to the adoption of novel methods, modifications that might be required, uncertainties in the application of certain methods, and suggestions for further research.
- Coordinate the development of publications — these may include white papers, peer-reviewed articles, workshops, and webinars that focus on the conceptual and empirical applications of alternative methods, assess their applicability and feasibility in HTA settings, and share research and policy perspectives with a broad set of HTA stakeholders.
For any questions related to HEMA’s structure or activities please reach out to Liis Shea, ICER’s Senior Program Director, at [email protected].
To learn more about the HEMA Working Group Principles, click here
